Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1976-9-25
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0067-7833
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
305-6
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1231765-Arterial Occlusive Diseases,
pubmed-meshheading:1231765-Blood Pressure,
pubmed-meshheading:1231765-Femoral Artery,
pubmed-meshheading:1231765-Humans,
pubmed-meshheading:1231765-Leg,
pubmed-meshheading:1231765-Prostaglandins E,
pubmed-meshheading:1231765-Regional Blood Flow,
pubmed-meshheading:1231765-Skin Temperature
|
pubmed:year |
1975
|
pubmed:articleTitle |
Vascular effect of prostaglandin (PGE1) infused into the femoral artery in normals and patients with occlusive arterial disease.
|
pubmed:publicationType |
Journal Article
|